Found: 23
Select item for more details and to access through your institution.
Discovery of Guanfacine as a Novel TAAR1 Agonist: A Combination Strategy through Molecular Modeling Studies and Biological Assays.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 11, p. 1632, doi. 10.3390/ph16111632
- By:
- Publication type:
- Article
Novel Thiazole-Based SIRT2 Inhibitors Discovered via Molecular Modelling Studies and Enzymatic Assays.
- Published in:
- Pharmaceuticals (14248247), 2023, v. 16, n. 9, p. 1316, doi. 10.3390/ph16091316
- By:
- Publication type:
- Article
Magnolol and Luteolin Inhibition of α-Glucosidase Activity: Kinetics and Type of Interaction Detected by In Vitro and In Silico Studies.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 2, p. 205, doi. 10.3390/ph15020205
- By:
- Publication type:
- Article
Probing In Silico the Benzimidazole Privileged Scaffold for the Development of Drug-like Anti-RSV Agents.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 12, p. 1307, doi. 10.3390/ph14121307
- By:
- Publication type:
- Article
Evidence of Pyrimethamine and Cycloguanil Analogues as Dual Inhibitors of Trypanosoma brucei Pteridine Reductase and Dihydrofolate Reductase.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 7, p. 636, doi. 10.3390/ph14070636
- By:
- Publication type:
- Article
Journey on Naphthoquinone and Anthraquinone Derivatives: New Insights in Alzheimer's Disease.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 1, p. 33, doi. 10.3390/ph14010033
- By:
- Publication type:
- Article
New Insights into the Binding Features of F508del CFTR Potentiators: A Molecular Docking, Pharmacophore Mapping and QSAR Analysis Approach.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 12, p. 445, doi. 10.3390/ph13120445
- By:
- Publication type:
- Article
Novel 1-Amidino-4-Phenylpiperazines as Potent Agonists at Human TAAR1 Receptor: Rational Design, Synthesis, Biological Evaluation and Molecular Docking Studies.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 391, doi. 10.3390/ph13110391
- By:
- Publication type:
- Article
Quinolizidine-Derived Lucanthone and Amitriptyline Analogues Endowed with Potent Antileishmanial Activity.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 339, doi. 10.3390/ph13110339
- By:
- Publication type:
- Article
New insights into the structure of the trace amine-associated receptor 2: Homology modelling studies exploring the binding mode of 3-iodothyronamine.
- Published in:
- Chemical Biology & Drug Design, 2017, v. 89, n. 5, p. 790, doi. 10.1111/cbdd.12903
- By:
- Publication type:
- Article
Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 8084, doi. 10.3390/ijms21218084
- By:
- Publication type:
- Article
Efficacy of Novel Acridine Derivatives in the Inhibition of hPrP90-231 Prion Protein Fragment Toxicity.
- Published in:
- Neurotoxicity Research, 2011, v. 19, n. 4, p. 556, doi. 10.1007/s12640-010-9189-8
- By:
- Publication type:
- Article
Antiviral Activity of Benzimidazole Derivatives. I. Antiviral Activity of 1-Substituted-2-[(Benzotriazol-1/2-yl)methyl]benzimidazoles.
- Published in:
- Chemistry & Biodiversity, 2008, v. 5, n. 11, p. 2386, doi. 10.1002/cbdv.200890203
- By:
- Publication type:
- Article
Quinolizidinyl-benzimidazoles as Platelet-Antiaggregating Agents.
- Published in:
- Chemistry & Biodiversity, 2008, v. 5, n. 5, p. 714, doi. 10.1002/cbdv.200890068
- By:
- Publication type:
- Article
Discovery of a Novel Chemo-Type for TAAR1 Agonism via Molecular Modeling.
- Published in:
- Molecules, 2024, v. 29, n. 8, p. 1739, doi. 10.3390/molecules29081739
- By:
- Publication type:
- Article
Further Quinolizidine Derivatives as Antiarrhythmic Agents- 3.
- Published in:
- Molecules, 2023, v. 28, n. 19, p. 6916, doi. 10.3390/molecules28196916
- By:
- Publication type:
- Article
Anti-α-Glucosidase and Antiglycation Activities of α-Mangostin and New Xanthenone Derivatives: Enzymatic Kinetics and Mechanistic Insights through In Vitro Studies.
- Published in:
- Molecules, 2022, v. 27, n. 2, p. 547, doi. 10.3390/molecules27020547
- By:
- Publication type:
- Article
Primary anti-proliferative activity evaluation of 1-(quinolizidin-1'-yl)methyl- and 1-( $$\omega $$-tert-amino)alkyl-substituted 2-phenyl-, 2-benzyl- and 2-[(benzotriazol-1/2-yl)methyl]benzimidazoles on human cancer cell lines.
- Published in:
- Molecular Diversity, 2013, v. 17, n. 3, p. 409, doi. 10.1007/s11030-013-9440-3
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of Novel (thio)semicarbazone-Based Benzimidazoles as Antiviral Agents against Human Respiratory Viruses.
- Published in:
- Molecules, 2020, v. 25, n. 7, p. 1487, doi. 10.3390/molecules25071487
- By:
- Publication type:
- Article
Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-021-02213-0
- By:
- Publication type:
- Article
Synthesis and Antiplasmodial Activity of Novel Chloroquine Analogues with Bulky Basic Side Chains.
- Published in:
- ChemMedChem, 2015, v. 10, n. 9, p. 1570, doi. 10.1002/cmdc.201500195
- By:
- Publication type:
- Article
Multitarget Therapeutic Leads for Alzheimer's Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and β-Amyloid (Aβ) Aggregation.
- Published in:
- ChemMedChem, 2015, v. 10, n. 6, p. 1040, doi. 10.1002/cmdc.201500104
- By:
- Publication type:
- Article
Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells.
- Published in:
- Molecular Neurobiology, 2016, v. 53, n. 1, p. 57, doi. 10.1007/s12035-014-8982-4
- By:
- Publication type:
- Article